Impaired antioxidant status and decreased dietary intake of antioxidants in patients with systemic lupus erythematosus

被引:35
作者
Bae, SC
Kim, SJ
Sung, MK [1 ]
机构
[1] Sookmyung Womens Univ, Dept Food & Nutr, Seoul 140742, South Korea
[2] Hanyang Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea
[3] Hosp Rheumat Dis, Seoul, South Korea
关键词
systemic lupus erythematosus; antioxidant; diet; nutrition; tocopherol;
D O I
10.1007/s00296-002-0241-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study compared plasma antioxidant/oxidant status and the dietary nutrient intake of patients with systemic lupus erythematosus (SLE) to those of healthy controls. Patients and methods The study included 97 consecutive patients with SLE and 97 age- and sex-matched healthy controls. Blood samples from 19 patients and 19 controls were subjected to analyses of plasma concentrations of alpha-tocopherol and malone dialdehyde and the activities of superoxide dismutase and glutathione peroxidase in the plasma. All patients and controls were interviewed using a semi-quantitative food-frequency questionnaire. Results The plasma alpha-tocopherol concentration was lower in patients, but this difference was not statistically significant. Plasma superoxide dismutase and glutathione peroxidase activities were significantly lower in patients than in controls, and the plasma malone dialdehyde level was significantly higher in patients than in controls. The intake of all major dietary antioxidants, including vitamin A. beta-carotene, and vitamin C, but not retinol, was lower in patients than in controls, but this difference was significant only for vitamin A and beta-carotene. Conclusions These results show that plasma antioxidant status is impaired and dietary antioxidant intake is decreased in patients with SLE.
引用
收藏
页码:238 / 243
页数:6
相关论文
共 13 条
[1]   Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus [J].
Comstock, GW ;
Burke, AE ;
Hoffman, SC ;
Helzlsouer, KJ ;
Bendich, A ;
Masi, AT ;
Norkus, EP ;
Malamet, RL ;
Gershwin, ME .
ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (05) :323-325
[2]   Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders [J].
Darlington, LG ;
Stone, TW .
BRITISH JOURNAL OF NUTRITION, 2001, 85 (03) :251-269
[3]  
FLOHE L, 1984, METHOD ENZYMOL, V105, P114
[4]  
Flohe L, 1988, CRC HDB FREE RADICAL, P287
[5]   The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus [J].
Gladman, D ;
Ginzler, E ;
Goldsmith, C ;
Fortin, P ;
Liang, M ;
Urowitz, M ;
Bacon, P ;
Bombardieri, S ;
Hanly, J ;
Hay, E ;
Isenberg, D ;
Jones, J ;
Kalunian, K ;
Maddison, P ;
Nived, O ;
Petri, M ;
Richter, M ;
SanchezGuerrero, J ;
Snaith, M ;
Sturfelt, G ;
Symmons, D ;
Zoma, A .
ARTHRITIS AND RHEUMATISM, 1996, 39 (03) :363-369
[6]   SERUM ANTIOXIDANTS AND RISK OF RHEUMATOID-ARTHRITIS [J].
HELIOVAARA, M ;
KNEKT, P ;
AHO, K ;
AARAN, RK ;
ALFTHAN, G ;
AROMAA, A .
ANNALS OF THE RHEUMATIC DISEASES, 1994, 53 (01) :51-53
[7]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725
[8]   Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis [J].
Knekt, P ;
Heliövaara, M ;
Aho, K ;
Alfthan, G ;
Marniemi, J ;
Aromaa, A .
EPIDEMIOLOGY, 2000, 11 (04) :402-405
[9]  
*KOR MIN HLTH WELF, 1999, REP 1998 KOR NAT HLT
[10]   REACTIVE OXYGEN SPECIES, LIPID PEROXIDES AND ESSENTIAL FATTY-ACIDS IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
SURYAPRABHA, P ;
DAS, UN ;
RAMESH, G ;
KUMAR, KV ;
KUMAR, GS .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1991, 43 (04) :251-255